What does SOLIMED TRADING & CONSULTING do?

SOLIMED TRADING & CONSULTING is a commercial agency in De Haan. Private Limited, started on 9 July 2008, 1 establishment.

What is the address of SOLIMED TRADING & CONSULTING?

The registered office of SOLIMED TRADING & CONSULTING is located at Prins Karellaan 5, 8421 De Haan.

Is SOLIMED TRADING & CONSULTING still active?

Yes. According to the CBE (19 September 2026) SOLIMED TRADING & CONSULTING is active, legal situation “Normale toestand”, started on 9 July 2008.

Is SOLIMED TRADING & CONSULTING registered on Peppol?

Yes, SOLIMED TRADING & CONSULTING is registered on the Peppol network with ID 0208:0899162680.

What is the enterprise number of SOLIMED TRADING & CONSULTING?

The enterprise number of SOLIMED TRADING & CONSULTING is BE0899162680.

When was SOLIMED TRADING & CONSULTING founded?

SOLIMED TRADING & CONSULTING was founded on 9 July 2008.

Who are the directors of SOLIMED TRADING & CONSULTING?

According to the 2025 annual accounts, the directors of SOLIMED TRADING & CONSULTING are: Paul GENNOTTE.

Is SOLIMED TRADING & CONSULTING a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 July 2008; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did SOLIMED TRADING & CONSULTING make in 2025?

SOLIMED TRADING & CONSULTING posted a profit after taxes of € 59,114 in financial year 2025.

What is the revenue of SOLIMED TRADING & CONSULTING?

As a small company, SOLIMED TRADING & CONSULTING is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 82,579.

Does SOLIMED TRADING & CONSULTING have a website?

Yes, SOLIMED TRADING & CONSULTING has a website at solimed.eu.

SOLIMED TRADING & CONSULTING (Private Limited) - De Haan

Dossier SOLIMED TRADING & CONSULTING, printed on 19 September 2026 from databakkes.be/en/0899162680/solimed-trading-consulting. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

SOLIMED TRADING & CONSULTING from De Haan, company number BE0899162680, closed financial year 2025 with a result of € 59,114 after tax. For that financial year SOLIMED TRADING & CONSULTING recorded a gross margin of € 82,579 and equity of € 353,710. Compared with financial year 2024, the result moved from € 19,657 to € 59,114. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 27, 2026.

What it is worth Growing

€ 353,710

▲ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 59,114

▲ 201% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 15,714

▲ 164% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 46,433 paid out

79 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 3,227

▼ 19% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 999

▼ 45% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 23,208

▲ 128% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 10,054

▲ 196% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 114,187 Gross margin 2022: € 114,187 First fiscal year in the series	€ 85,912 Gross margin 2023: € 85,912 ▼ 25% vs 2022 (€ 114,187) Unfavourable step	€ 51,198 Gross margin 2024: € 51,198 ▼ 40% vs 2023 (€ 85,912) Unfavourable step	€ 82,579 Gross margin 2025: € 82,579 ▲ 61% vs 2024 (€ 51,198) Favourable step	▲ 61%
Profit after taxes	€ 58,478 Profit after taxes 2022: € 58,478 First fiscal year in the series	€ 35,173 Profit after taxes 2023: € 35,173 ▼ 40% vs 2022 (€ 58,478) Unfavourable step	€ 19,657 Profit after taxes 2024: € 19,657 ▼ 44% vs 2023 (€ 35,173) Unfavourable step	€ 59,114 Profit after taxes 2025: € 59,114 ▲ 201% vs 2024 (€ 19,657) Favourable step	▲ 201%
Equity	€ 310,236 Equity 2022: € 310,236 First fiscal year in the series	€ 339,580 Equity 2023: € 339,580 ▲ 9% vs 2022 (€ 310,236) Favourable step	€ 341,029 Equity 2024: € 341,029 Unchanged (€ 339,580) Favourable step	€ 353,710 Equity 2025: € 353,710 ▲ 4% vs 2024 (€ 341,029) Favourable step	▲ 4%
Total debts	€ 52,852 Total debts 2022: € 52,852 First fiscal year in the series	€ 31,867 Total debts 2023: € 31,867 ▼ 40% vs 2022 (€ 52,852) Favourable step	€ 33,686 Total debts 2024: € 33,686 ▲ 6% vs 2023 (€ 31,867) Unfavourable step	€ 82,393 Total debts 2025: € 82,393 ▲ 145% vs 2024 (€ 33,686) Unfavourable step	▲ 145%
Cash	€ 44,937 Cash 2022: € 44,937 First fiscal year in the series	€ 68,129 Cash 2023: € 68,129 ▲ 52% vs 2022 (€ 44,937) Favourable step	€ 5,942 Cash 2024: € 5,942 ▼ 91% vs 2023 (€ 68,129) Unfavourable step	€ 15,714 Cash 2025: € 15,714 ▲ 164% vs 2024 (€ 5,942) Favourable step	▲ 164%
Land & buildings	€ 82,632 Land & buildings 2022: € 82,632 First fiscal year in the series	€ 70,421 Land & buildings 2023: € 70,421 ▼ 15% vs 2022 (€ 82,632) Unchanged	€ 66,849 Land & buildings 2024: € 66,849 ▼ 5% vs 2023 (€ 70,421) Unchanged	€ 65,429 Land & buildings 2025: € 65,429 ▼ 2% vs 2024 (€ 66,849) Unchanged	▼ 2%
Retained profit	€ 161,636 Retained profit 2022: € 161,636 First fiscal year in the series	€ 190,980 Retained profit 2023: € 190,980 ▲ 18% vs 2022 (€ 161,636) Favourable step	€ 192,429 Retained profit 2024: € 192,429 ▲ 1% vs 2023 (€ 190,980) Favourable step	€ 205,110 Retained profit 2025: € 205,110 ▲ 7% vs 2024 (€ 192,429) Favourable step	▲ 7%
Dividend	€ 10,800 Dividend 2022: € 10,800 First fiscal year in the series	€ 5,829 Dividend 2023: € 5,829 ▼ 46% vs 2022 (€ 10,800) Unchanged	€ 18,209 Dividend 2024: € 18,209 ▲ 212% vs 2023 (€ 5,829) Unchanged	€ 46,433 Dividend 2025: € 46,433 ▲ 155% vs 2024 (€ 18,209) Unchanged	▲ 155%
Bank debt	€ 1,950 Bank debt 2022: € 1,950 First fiscal year in the series	€ 517 Bank debt 2023: € 517 ▼ 74% vs 2022 (€ 1,950) Favourable step	€ 1,819 Bank debt 2024: € 1,819 ▲ 252% vs 2023 (€ 517) Unfavourable step	€ 999 Bank debt 2025: € 999 ▼ 45% vs 2024 (€ 1,819) Favourable step	▼ 45%
Balance sheet total	€ 363,088 Balance sheet total 2022: € 363,088 First fiscal year in the series	€ 371,447 Balance sheet total 2023: € 371,447 ▲ 2% vs 2022 (€ 363,088) Unchanged	€ 374,714 Balance sheet total 2024: € 374,714 ▲ 1% vs 2023 (€ 371,447) Unchanged	€ 436,103 Balance sheet total 2025: € 436,103 ▲ 16% vs 2024 (€ 374,714) Unchanged	▲ 16%

Key figures of SOLIMED TRADING & CONSULTING, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to SOLIMED TRADING & CONSULTING?

What happened at SOLIMED TRADING & CONSULTING in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 27, 2026 New annual accounts for financial year 2025: profit of € 59,114 (▲ 201% vs 2024). Source: NBB ↗
Mar 1, 2013 New establishment in De Haan. KBO
Jul 9, 2008 Start of the company according to the CBE. KBO
2008 Paul GENNOTTE became a director. NBB

In short

From € 58,478 profit in 2022 to € 59,114 profit in 2025.

Paid € 68,296 in corporate taxes since 2022.

Best year ever: 2025, with € 59,114 profit.

Paid out € 81,270 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at SOLIMED TRADING & CONSULTING? We notify you, reason included.

Follow SOLIMED TRADING & CONSULTING

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Paul GENNOTTE

SOLIMED TRADING & CONSULTING

Behind SOLIMED TRADING & CONSULTING is Paul GENNOTTE.

See the full network in the app

Directors

According to the 2025 annual accounts

Paul GENNOTTE

Director

since 2008

Establishments

Establishment units

Physical locations of this company

Registered office

Prins Karellaan 5

8421 De Haan

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS solimed.eu

About

Technologies

AWS S3Google FontsPHPjQuery

Hosting & Email

Email provider

OVH Mail

Hosting

OVH, FR

DNS

OVH DNS

Domain

solimed.eu

Registrar

OVH SAS

Website info

HTTPS Ja

Languages NL

Features

Security

✓ HTTPS

✓ SPF

✓ DMARC

Details

Company number

0899.162.680

VAT number

BE 0899.162.680

Registered office

Prins Karellaan 5, 8421 De Haan

Names & denominations

SOLIMED TRADING & CONSULTING · SOLIMED

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

9 July 2008

Peppol

Active · Active since 28 Oct 2024

Contact